XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Schedule of option activity
             
       Weighted   Weighted
       Average   Average
   Number of   Exercise   Remaining
   Options   Price   Contractual Life
Outstanding at December 31, 2022   336,758    12.54    
Granted   10,000    17.55    
Outstanding at March 31, 2023   346,758   $12.68   6.88 Years
Assumptions for options granted
   Three months ended March 31, 
   2023   2022 
Expected Volatility   95%    97.40% - 97.41% 
Expected Term   7 Years    7 Years 
Risk-free interest rate   3.55%    1.55% - 1.71% 
Weighted-average FV  $14.28   $14.31 
Schedule of restricted stock award activity
          
       Weighted- 
   Nonvested   Average Grant- 
   Shares   Date Fair Value 
Nonvested at December 31, 2022   17,865   $14.11 
Vested   (5,966)   12.75 
Nonvested at March 31, 2023   11,899   $14.79 
Schedule of common stock warrant activity
          
   Number of Warrants   Weighted Average Exercise Price 
Outstanding at December 31, 2022   440,204   $9.73 
Granted   200,000   $17.00 
Exercised   (15,898)  $6.30 
Outstanding at March 31, 2023   624,306   $9.73 
Exercisable at March 31, 2023   424,306   $6.30